Petrelintide acetate salt form · acetate (1:x) · Parent Petrelintide · Synonyms: ZP8396 acetate
Perelintide acetate is an amylin analog.
For research use only. Not for human or veterinary use.
Target
Amylin Receptor
Research area
Metabolic Disease
Purity >98%
Description
Perelintide (ZP8396) acetate is an amylin analog that shows potential for reducing body weight. Petrelintide can be used in diabetes research. Petrelintide demonstrates agonistic activity against hAMY3R and hCTR in HEK-293 cells, with EC50 of 2.997 and 9.215 nM, respectively.
Specifications
- MW (average)
- 4191.6900 (free base)
- Formula
- C185H305N49O61
- CAS No.
- 2766385-23-1 (free base)
- Physical state
- Solid
- Color
- White to off-white
- Shipping
- Room temperature in continental US; may vary elsewhere.
- Storage
- Powder -20°C 2 years; 4°C 1 year; In solvent -80°C 6 months; -20°C 1 month
Solubility
Soluble in water
- In vitro
- Soluble in DMSO
Documents
References
[1]. JON G, et al. 1668-P: Novel Once-Weekly Amylin Analog Petrelintide (ZP8396) Is Well Tolerated with Improved GI Tolerability after Multiple Dosing, Diabetes, 2024;73(Supplement_1):1668-P
[2]. BILL V, et al. 1661-P: Petrelintide (ZP8396) Selectively Reduces Intake of High-Fat Diet in DIO Rats. Diabetes 14 June 2024; 73 (Supplement_1): 1661-P.
Same research area
Search Metabolic Disease- BP-00756 PF-07853578 free base · >98%
- BP-00906 TYRA-300 free base · >98%
- BP-01096 PROTAC AR Degrader-5 free base · >98%
- BP-01635 PF-04620110 free base · >98%
- BP-01673 Casein Kinase II Inhibitor IV free base · >98%
- BP-01824 TAK875 free base · >98%
- BP-01828 3-Deazaneplanocin A free base · >98%
- BP-01829 SYR-472 succinate free base · >98%